Abiopharma

🔍 Zhang Kevin Xiaoqiang (Executive)

Company: TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD (TSM)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Acquired 20,313 shares of Common Shares (2330.TW) (Direct)
  Date: 2026-09-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 349,976.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of American Depositary Shares (TSM) (Direct)
  Date: 2026-09-01 | Code: H | shares_owned_after: 2,500.00 | Footnotes: F2
• Holds 0 shares of Common Shares (2330.TW) (Direct)
  Date: 2026-09-01 | Code: H | nature_of_ownership: By ESPP Trust | shares_owned_after: 7,286.00 | Footnotes: F3
• Holds 0 shares of Common Shares (2330.TW) (Direct)
  Date: 2026-09-01 | Code: H | nature_of_ownership: By LTI Trust | shares_owned_after: 20,190.00 | Footnotes: F4

Footnotes:

• F1: Represents Common Shares vested on September 1, 2026 in accordance with the issuer's Employee Restricted Stock Awards Rules.
• F2: Each American Depositary Share represents five (5) Common Shares.
• F3: Common Shares purchased and held under the issuer's Employee Stock Purchase Plan ("ESPP").
• F4: Represents Common Shares purchased by a trust with cash received under the issuer's Long-Term Incentive ("LTI") Bonus Plan, over which the filer has obtained investment control.